提高小肾肿块诊断准确性:多参数MRI中影像组学与透明细胞可能性评分的整合
这项回顾性研究纳入68例患者的72个小肾肿块(43个透明细胞肾癌、29个非透明细胞肾癌),评估多参数MRI影像组学联合透明细胞可能性评分(ccLS)鉴别透明细胞肾癌的效能。ccLS≥4诊断透明细胞肾癌的敏感度83.3%、特异度73.3%;联合影像组学后敏感度90.7%、特异度78.4%、AUC 0.88。在ccLS 3(不确定)病灶中,单独影像组学鉴别透明细胞肾癌的敏感度100%、特异度62.5%。
要点
- 联合影像组学与ccLS鉴别透明细胞肾癌的敏感度90.7%、特异度78.4%、AUC 0.88。
- ccLS≥4单独诊断透明细胞肾癌的敏感度83.3%、特异度73.3%。
- ccLS 3(不确定)病灶中,影像组学单独鉴别透明细胞肾癌的敏感度100%、特异度62.5%。
核心结论
- 影像组学分析能成功鉴别ccLS 3的病灶,影像组学联合ccLS能成功鉴别透明细胞肾癌与非透明细胞肾癌。
研究设计与样本
- 回顾性研究,纳入68例患者共72个cT1a肾肿块(43个透明细胞肾癌、29个非透明细胞肾癌),术前接受多参数MRI(T2加权成像与对比增强T1加权成像序列)并接受肾切除术。
诊断标准与关键数值
- ccLS单独以ccLS≥4判定透明细胞肾癌,敏感度83.3%、特异度73.3%。影像组学特征在不同特征间AUC为0.48至0.87。影像组学联合ccLS鉴别透明细胞肾癌,敏感度90.7%、特异度78.4%、AUC 0.88。ccLS 3(不确定)病灶中,影像组学单独鉴别透明细胞肾癌,敏感度100%、特异度62.5%。
临床应用与阅片要点
- 对cT1a肾肿块可行多参数MRI并采用ccLS version 2.0进行定性评估。
- ccLS≥4时可按透明细胞肾癌判读,原文报告敏感度83.3%、特异度73.3%。
- ccLS 3(不确定)病灶可结合影像组学分析,原文报告单独影像组学敏感度100%、特异度62.5%。
- 影像组学联合ccLS可提高透明细胞肾癌鉴别效能,原文报告敏感度90.7%、特异度78.4%、AUC 0.88。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Accurate diagnosis of small renal masses is crucial for treatment planning. Combining radiomics analysis with the Clear Cell Likelihood Score (ccLS) in multiparametric MRI can effectively assess malignancy risk. This study aimed to evaluate the contribution of MRI-based radiomics analysis to the diagnostic performance of the ccLS in differentiating clear cell renal carcinoma (ccRCC).
MATERIALS AND METHODS: This retrospective study included patients with cT1a renal masses who underwent preoperative MRI and nephrectomy. Radiomic features were extracted from multiparametric MRI images, including T2-weighted imaging and contrast-enhanced T1-weighted imaging sequences. Qualitative assessment was performed using the ccLS version 2.0, based on multiparametric MRI findings. The diagnostic efficacies of the ccLS, radiomic analysis, and the combination of the two methods in differentiating ccRCCs were analyzed.
RESULTS: A total of 72 small renal masses (43 ccRCC and 29 non-ccRCC) from 68 patients were evaluated. Using ccLS alone, lesions classified as ccLS ≥ 4 were identified as ccRCCs with a sensitivity of 83.3% and specificity of 73.3%. Radiomic analysis revealed significant differences between ccRCC and non-ccRCC lesions, with AUC values ranging from 0.48 to 0.87 across different features. The combined use of radiomic features and ccLS improved the differentiation of ccRCCs, achieving a sensitivity of 90.7%, specificity of 78.4%, and an AUC of 0.88. In lesions classified as ccLS 3 (equivocal), radiomic analysis alone distinguished ccRCCs with 100% sensitivity and 62.5% specificity.
CONCLUSIONS: This study's findings demonstrated that radiomics analysis successfully differentiated lesions with a ccLS 3 and that the use of radiomic analysis in combination with ccLS successfully differentiated ccRCC and non-ccRCC lesions.
引用
- Cakir IM, Eryuruk U, Gurun E, et al. Improving the diagnostic accuracy of small renal masses: Integration of radiomics and clear cell likelihood scores in multiparametric MRI. Eur J Radiol. 2025. PMID: 40408912. doi:10.1016/j.ejrad.2025.112174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。